Soumit Roy analyst JONESTRADING

Currently out of the existing stock ratings of Soumit Roy, 34 are a BUY (73.91%), 12 are a HOLD (26.09%).

Soumit Roy

Work Performance Price Targets & Ratings Chart

Analyst Soumit Roy, currently employed at JONESTRADING, carries an average stock price target met ratio of 24.6% that have a potential upside of 53.39% achieved within 54 days.

Soumit Roy’s has documented 82 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ONCY, Oncolytics Biotech at 15-May-2025.

Wall Street Analyst Soumit Roy

Analyst best performing recommendations are on CGEM (CULLINAN ONCOLOGY LLC).
The best stock recommendation documented was for CGEM (CULLINAN ONCOLOGY LLC) at 4/17/2024. The price target of $26 was fulfilled within 12 days with a profit of $8.12 (45.41%) receiving and performance score of 37.84.

Average potential price target upside

DCPH Deciphera Pharmaceuticals LLC INFI Infinity Pharmaceuticals AVEO AVEO Pharmaceuticals SAVA Cassava Sciences SBTX Silverback Therapeutics  IKT Inhibikase Therapeutics  RAIN Rain Therapeutics TCON TRACON Pharmaceuticals MRTX Mirati Ther MNPR Monopar Therapeutics INAB In8bio  CGEM Cullinan Oncology LLC DTIL Precision BioSciences JANX Janux Therapeutics APTO Aptose Biosciences ACRV Acrivon Therapeutics, Common Stock CRVO CervoMed BEAM Beam Therapeutics  CMRX Chimerix CRIS Curis ONCY Oncolytics Biotech

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$23

$-2.59 (-10.12%)

$23

1 years 5 months 2 days ago
(09-May-2024)

6/9 (66.67%)

$-2.36 (-9.31%)

90

Sell

$26

$0.41 (1.60%)

$9

1 years 5 months 12 days ago
(29-Apr-2024)

3/10 (30%)

$0.73 (2.89%)

235

Hold

$22

1 years 5 months 12 days ago
(29-Apr-2024)

2/3 (66.67%)

$2.24 (11.34%)

67

Hold

$23

1 years 5 months 13 days ago
(28-Apr-2024)

4/6 (66.67%)

$8.58 (59.50%)

352

Hold

$16

$-9.59 (-37.48%)

1 years 5 months 13 days ago
(28-Apr-2024)

0/3 (0%)

$-9.28 (-36.71%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Soumit Roy is most bullish on?

Potential upside of $0 has been obtained for ONCY (ONCOLYTICS BIOTECH)

What Year was the first public recommendation made by Soumit Roy?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?